This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly those involving serotonin and dopamine pathways. Its structural properties make it suitable for creating enantiomerically pure compounds, which are essential for producing medications with high efficacy and minimal side effects. Additionally, it is employed in research settings for studying receptor interactions and developing novel therapeutic agents. Its difluoromethoxy group enhances metabolic stability, making it valuable in the design of drugs with improved pharmacokinetic profiles.